Manulife (Manufacturers Life Insurance)’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,040
Closed -$138K 2891
2025
Q4
$138K Sell
10,040
-348
-3% -$5.42K ﹤0.01% 2643
2025
Q3
$184K Sell
10,388
-102
-1% -$1.61K ﹤0.01% 2609
2025
Q2
$158K Buy
+10,490
New +$174K ﹤0.01% 2642
2021
Q2
Sell
-8,490
Closed -$201K 3271
2021
Q1
$201K Sell
8,490
-721
-8% -$21.6K ﹤0.01% 2892
2020
Q4
$220K Buy
+9,211
New +$147K ﹤0.01% 2723
2018
Q3
Sell
-5,985
Closed -$90K 3638
2018
Q2
$90K Buy
5,985
+5,548
+1,270% +$93.9K ﹤0.01% 3442
2018
Q1
$6K Sell
437
-6,858
-94% -$130K ﹤0.01% 4066
2017
Q4
$172K Buy
7,295
+6,908
+1,785% +$163K ﹤0.01% 3115
2017
Q3
$7K Sell
387
-6,823
-95% -$155K ﹤0.01% 3951
2017
Q2
$250K Buy
+7,210
New +$198K ﹤0.01% 2830

Other funds holding PLSE

Manulife (Manufacturers Life Insurance)'s PLSE Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of Pulse Biosciences (PLSE) in Q1 2026, closing a stake of 10,040 shares — an estimated $138K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PLSE in Q2 2017 and held it in 10 quarters. The position peaked at $250K in Q2 2017. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) reported no remaining Pulse Biosciences position as of Q1 2026 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 10,040 Pulse Biosciences shares in Q1 2026, an estimated $138K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Pulse Biosciences in Q2 2017 and held it in 10 quarters.
  • Manulife (Manufacturers Life Insurance)'s Pulse Biosciences position peaked at $250K in Q2 2017.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.